These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19470939)

  • 1. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.
    Pierce BL; Ballard-Barbash R; Bernstein L; Baumgartner RN; Neuhouser ML; Wener MH; Baumgartner KB; Gilliland FD; Sorensen BE; McTiernan A; Ulrich CM
    J Clin Oncol; 2009 Jul; 27(21):3437-44. PubMed ID: 19470939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
    Pierce BL; Neuhouser ML; Wener MH; Bernstein L; Baumgartner RN; Ballard-Barbash R; Gilliland FD; Baumgartner KB; Sorensen B; McTiernan A; Ulrich CM
    Breast Cancer Res Treat; 2009 Mar; 114(1):155-67. PubMed ID: 18401703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
    Allin KH; Nordestgaard BG; Flyger H; Bojesen SE
    Breast Cancer Res; 2011 Jun; 13(3):R55. PubMed ID: 21639875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
    Villaseñor A; Ambs A; Ballard-Barbash R; Baumgartner KB; McTiernan A; Ulrich CM; Neuhouser ML
    Breast Cancer Res Treat; 2011 Sep; 129(2):485-94. PubMed ID: 21455669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
    Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
    Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study.
    Kälsch AI; Scharnagl H; Kleber ME; Windpassinger C; Sattler W; Leipe J; Krämer BK; März W; Malle E
    Clin Res Cardiol; 2020 Mar; 109(3):358-373. PubMed ID: 31263995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study.
    Villaseñor A; Flatt SW; Marinac C; Natarajan L; Pierce JP; Patterson RE
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):189-99. PubMed ID: 24220913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
    Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
    Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups.
    Holm JB; Baggesen E; Cronin-Fenton D; Frystyk J; Bruun JM; Christiansen P; Borgquist S
    Sci Rep; 2024 Jun; 14(1):14486. PubMed ID: 38914635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a cross-sectional analysis.
    Dee A; McKean-Cowdin R; Neuhouser ML; Ulrich C; Baumgartner RN; McTiernan A; Baumgartner K; Alfano CM; Ballard-Barbash R; Bernstein L
    BMC Cancer; 2012 Aug; 12():343. PubMed ID: 22873489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.
    Zhang XY; Zhang G; Jiang Y; Liu D; Li MZ; Zhong Q; Zeng SQ; Liu WL; Zeng MS
    Chin J Cancer; 2015 Aug; 34(8):335-49. PubMed ID: 26264146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.
    George SM; Neuhouser ML; Mayne ST; Irwin ML; Albanes D; Gail MH; Alfano CM; Bernstein L; McTiernan A; Reedy J; Smith AW; Ulrich CM; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2220-8. PubMed ID: 20716617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes.
    Kosuge M; Ebina T; Ishikawa T; Hibi K; Tsukahara K; Okuda J; Iwahashi N; Ozaki H; Yano H; Kusama I; Nakati T; Umemura S; Kimura K
    Circ J; 2007 Feb; 71(2):186-90. PubMed ID: 17251664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
    Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient.
    Hogarth MB; Gallimore R; Savage P; Palmer AJ; Starr JM; Bulpitt CJ; Pepys MB
    Age Ageing; 1997 Mar; 26(2):153-8. PubMed ID: 9177673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors.
    Alfano CM; Imayama I; Neuhouser ML; Kiecolt-Glaser JK; Smith AW; Meeske K; McTiernan A; Bernstein L; Baumgartner KB; Ulrich CM; Ballard-Barbash R
    J Clin Oncol; 2012 Apr; 30(12):1280-7. PubMed ID: 22412148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute phase response in breast carcinoma.
    O'Hanlon DM; Lynch J; Cormican M; Given HF
    Anticancer Res; 2002; 22(2B):1289-93. PubMed ID: 12168939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study.
    Haarala A; Kähönen M; Eklund C; Jylhävä J; Koskinen T; Taittonen L; Huupponen R; Lehtimäki T; Viikari J; Raitakari OT; Hurme M
    Eur J Clin Invest; 2011 Sep; 41(9):951-7. PubMed ID: 21323913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.